An FDA investigator or an EU inspector sends the dates and a list of what they will read. Quality spends the days before pulling it all into one binder, and the inspector reads it in a morning.
From preclinical
to commercial supply
Procedures, training, deviations and CAPAs. Change control and suppliers. Assessed against the standard each phase brings.

THE BINDER GETS BUILT THE WEEK BEFORE
Preparing for the inspection takes longer than the inspection
Training sits in the LMS
Completions are exported and reconciled by hand.
Deviations sit in a tracker
Each one is chased to its CAPA before it goes in the binder.
Supplier audits sit in an inbox
The reports are found and filed the week before.
THE AUDIT PACK IS ALREADY BUILT
Qualio runs the processes and assesses every record against cGMP
Qualio runs the processes the inspector reads, the deviation, the change control and the supplier qualification, each routed to the people who sign it. It maps cGMP, GCP and ICH Q10 to those records and assesses each against its clause as it changes, with a recommendation on every gap. When the dates come, Qualio exports the audit pack by clause with the evidence behind each, so the weeks before an inspection are ordinary weeks.
The Results
How it works
The shared drive, the training spreadsheet and the deviation tracker, retired
Qualio reads SharePoint and Confluence as they are, and ComplianceWire gets the approved procedure for training.
Quality Management
Qualio holds the procedures, training, deviations, CAPAs, change controls and supplier files the whole company works in, so the inspector reads the approved version of each.
Compliance Frameworks
Qualio maps cGMP, GCP, ICH Q7 and Q10 once and assesses every record clause by clause as it changes, so you find each gap before the inspector does.
Copilot
Drafts the deviation write-up, the change control, the SCAR and the training quiz from your own records. Every output cites its source and waits for your approval.
DEVIATIONS, OOS AND CAPA UNDER cGMP
Every deviation is traceable from the batch to the CAPA that closed it

CHANGE CONTROL UNDER ICH Q10 AND PART 11
A process change retrains the people it affects before it takes effect

SUPPLIERS, CDMOs AND CROs UNDER cGMP
Supplier quality sits beside the deviations it causes, CDMO included

CELL, GENE AND TISSUE UNDER 21 CFR PART 1271
Donor to dose, on the same procedures the inspector reads
Qualio maps 21 CFR Part 1271, the FDA's Current Good Tissue Practice for HCT/Ps, and the AATB standards beside cGMP, and assesses your procedures and records against every standard that applies.
Donor eligibility
Screening and testing procedures and records, assessed against Part 1271.
Manufacturing controls
Processing, storage and distribution procedures, assessed against Current Good Tissue Practice.
Adverse event reporting
Each report logged as a quality event, with its investigation and CAPA linked.
What pharma and biotech companies say
“Qualio simplified things immensely.”
Andrew Breite
Director of Quality Assurance, VitaCyte

“With other vendors, we felt like just a number. But this is like a true partnership. Qualio has definitely changed our world.”
Eric Day
Director of Quality Assurance, Expression Therapeutics

“It's more than just my job and about having a team that does quality. It's about having everyone understand what quality means, having access to their work instructions, having a clean and straightforward way to do their jobs - whether that's someone in production or QA.”
Peter Bruesehoff
Director of Quality Assurance, Watchmaker Genomics





